| Literature DB >> 28810566 |
Yaqi Chen1, Mei Hu1, Hongying Gong1.
Abstract
The aim of this study was to investigate the correlation between the low-density lipoprotein cholesterol (LDL-C) in serum and the onset of transient ischemic attack caused by cerebral small vascular disease (CSVD). Between September 2012 and September 2015, 249 patients who were diagnosed as CSVD were randomly enrolled in this study. According to MRI results, patients were divided into the patient and control groups. In the patient group, the patients were further subdivided into the white matter lesion (WML) group (n=86) and lacunar infarction (LI) group (n=53). Head MRI and/or CT were conducted on all the patients. This included T1 and T2 phases, diffusion weighted imaging (DWI) and fluid attenuated inversion recovery (FLAIR). Additionally, mini-mental status examination (MMSE) test and Montreal cognitive assessment (MoCA) test were carried out on all the patients. As a result, the age, total cholesterol (TC) level and low-density lipoprotein (LDL) levels in the patient group were higher than those in the control group (p<0.05). The MMSE and MoCA scores in the patient group were significantly lower than those in the control group (p<0.05). With all the risk factors being set as independent variables and small vessel disease (SVD) as the dependent variable, we performed the logistic regression analysis and correlation analysis for paired data, and found that the increase in LDL was correlated to the onset of SVD, OR=1,321. After adjustment of other risk factors, we enrolled the level of triglyceride (TG) into the multivariable analysis and obtained a statistically significant difference (p<0.05). In conclusion, LDL is a major risk factor affecting the onset of transient ischemic attack (TIA) induced by CSVD. Patients with hyperlipidemia should receive head MRI or CT examination to eliminate the probability of the existence of CSVD. To reduce the occurrence of adverse events in clinical practice, we can perform early intervention in SVD by decreasing the level of LDL, improving the endothelial function of small vessels and applying the anti-inflammation and nerve-protection methods.Entities:
Keywords: logistic regression analysis; low-density lipoprotein; small vessel disease
Year: 2017 PMID: 28810566 PMCID: PMC5526171 DOI: 10.3892/etm.2017.4583
Source DB: PubMed Journal: Exp Ther Med ISSN: 1792-0981 Impact factor: 2.447
History of baseline diseases and clinical data of enrolled patients (mean ± SD).
| Group | Sex (male/female) | Age | Cases (n) | Weight (kg) | Height (cm) | BMI |
|---|---|---|---|---|---|---|
| Patient group | 76/63 | 54.3±16.4 | 139 | 70.2±21.5 | 169.7±20.4 | 30.85±14.64 |
| Control group | 61/46 | 46.5±17.3 | 107 | 68.4±19.8 | 160.2±15.3 | 28.63±16.71 |
| F-value | 0.82 | – | 0.79 | 0.84 | 0.63 | |
| P-value | >0.05 | – | >0.05 | >0.05 | >0.05 |
Figure 1.MRI images for CSVD. (A) (MRI FLAIR): right cerebral hemisphere (i.e., left part of the figure): leukoaraiosis (arrow), and acute cerebral infarction in left cerebral hemisphere (i.e., right part of the figure). Corresponding patient with acute cerebral infarction. (B) (MRI FLAIR): leukoaraiosis (arrow). Corresponding patient with TIA. (C) (MRI FLAIR): leukoaraiosis (arrow). Corresponding patient with TIA. (D) (MRI FLAIR): leukoaraiosis (arrow). Corresponding patient with TIA. (E) (MRI FLAIR): right cerebral hemisphere (i.e., left part of the figure): leukoaraiosis (arrow), and acute cerebral infarction in left cerebral hemisphere (i.e., right part of the figure). Corresponding patient with acute cerebral infarction. (F) (MRI FLAIR): right cerebral hemisphere (i.e., left part of the figure): leukoaraiosis (arrow), and acute cerebral infarction in left cerebral hemisphere (i.e., right part of the figure). (E and F) for the same corresponding patient with acute cerebral infarction. (G) (MRI FLAIR): LI (arrow). Corresponding patient with TIA. (H) (MRI FLAIR): bilateral LI (arrow). Corresponding patient with TIA. (I) (MRI FLAIR): bilateral LI (arrow). Corresponding patient with TIA. CSVD, cerebral small vascular disease; FLAIR, fluid attenuated inversion recovery; TIA, transient ischemic attack; LI, lacunar infarction.
Statistics of categorized test for risk factors of patients in each group (mean ± SD).
| Indexes | Group | Cases | Detection results |
|---|---|---|---|
| Fasting blood glucose (mmol/l) | Control group | 107 | 5.68±7.51 |
| WML group | 86 | 6.32±3.3 | |
| LI group | 53 | 5.87±4.6 | |
| F-value | – | 0.62 | |
| P-value | – | >0.05 | |
| Systolic pressure (mmHg) | Control group | 107 | 119.3±25.3 |
| WML group | 86 | 136.7±13.5 | |
| LI group | 53 | 128.2±22.8 | |
| F-value | – | 0.94 | |
| P-value | – | >0.05 | |
| Diastolic pressure (mmHg) | Control group | 107 | 92.12±9.6 |
| WML group | 86 | 87.81±10.2 | |
| LI group | 53 | 95.63±15.7 | |
| F-value | – | 0.72 | |
| P-value | – | >0.05 | |
| LDL-C (mmol/l) | Control group | 107 | 1.58±2.67 |
| WML group | 86 | 3.15±1.21 | |
| LI group | 53 | 4.65±0.86 | |
| F-value | – | 1.95 | |
| P-value | – | <0.05 | |
| HDL-C (mmol/l) | Control group | 107 | 1.45±1.22 |
| WML group | 86 | 0.97±0.63 | |
| LI group | 53 | 1.25±0.57 | |
| F-value | – | 0.83 | |
| P-value | – | >0.05 | |
| Cr (µmol/l) | Control group | 107 | 88.52±16.82 |
| WML group | 86 | 79.42±27.21 | |
| LI group | 53 | 90.16±25.33 | |
| F-value | – | 0.37 | |
| P-value | – | >0.05 | |
| TG (mmol/l) | Control group | 107 | 1.32±0.81 |
| WML group | 86 | 2.52±1.53 | |
| LI group | 53 | 2.87±1.36 | |
| F-value | – | 2.76 | |
| P-value | – | <0.05 | |
| Smoking duration (year) | Control group | 107 | 7.62±3.8 |
| WML group | 86 | 6.51±1.5 | |
| LI group | 53 | 8.42±1.6 | |
| F-value | – | 0.82 | |
| P-value | – | >0.05 | |
| Smoking amount (/day) | Control group | 107 | 15.27±10.36 |
| WML group | 86 | 18.48±9.68 | |
| LI group | 53 | 10.25±7.83 | |
| F-value | – | 0.98 | |
| P-value | – | >0.05 | |
| Drinking duration (year) | Control group | 107 | 5.87±4.81 |
| WML group | 86 | 5.77±6.74 | |
| LI group | 53 | 7.46±2.21 | |
| F-value | – | 0.34 | |
| P-value | – | >0.05 | |
| Drinking amount (ml/day) | Control group | 107 | 108.26±22.64 |
| WML group | 86 | 125.47±12.35 | |
| LI group | 53 | 116.35±23.56 | |
| F-value | – | 0.94 | |
| P-value | – | >0.05 | |
| Age (years) | Control group | 107 | 38.7±11.2 |
| WML group | 86 | 53.6±5.3 | |
| LI group | 53 | 58.2±7.7 | |
| F-value | – | 5.84 | |
| P-value | – | <0.05 | |
| TC (mmol/l) | Control group | 107 | 4.8±3.65 |
| WML group | 86 | 8.7±2.24 | |
| LI group | 53 | 6.8±1.24 | |
| F-value | – | 1.68 | |
| P-value | – | <0.05 |
WML, white matter lesion; LI, lacunar infarction; LDL-C, low-density lipoprotein cholesterol; Cr, creatinine; TG, triglyceride; TC, total cholesterol.
MMSE and MoCA examination.
| Group | Cases | MMSE score | MoCA score |
|---|---|---|---|
| Control group | 107 | 28.38±0.82 | 27.32±1.24 |
| WML group | 86 | 21.27±1.78 | 22.47±1.35 |
| LI group | 53 | 21.25±2.18 | 20.35±1.56 |
| F-value | – | 19.38 | 20.03 |
| P-value | – | 0.017 | 0.012 |
MMSE, mini mental status examination; MoCA, Montreal cognitive assessment; WML, white matter lesion; LI, lacunar infarction.
Analysis of correlation of CSVD-induced TIA with LDL-C and TG.
| LDL-C | TG | |||||
|---|---|---|---|---|---|---|
| CSVD | Positive[ | Negative | Positive[ | Negative | r | P-value |
| Positive | 139 | 0 | 125 | 11 | 0.108 | <0.05 |
| Negative | 23 | 86 | 17 | 90 | 0.024 | <0.05 |
CSVD positive refers that patients diagnosed as LI and/or WML.
LDL-C positive indicates that LDL-C was >4.14 mmol/l.
TG positive refers to the level of TG in plasma >1.65 mmol/l. CSVD, cerebral small vascular disease; TIA, transient ischemic attack; LDL-C, low-density lipoprotein cholesterol; TG, triglyceride; WML, white matter lesion; LI, lacunar infarction.